NCT07498725 2026-03-27
A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors
LARKSPUR BIOSCIENCES, INC.
Phase 1/2 Not yet recruiting
LARKSPUR BIOSCIENCES, INC.
Shanghai JMT-Bio Inc.
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
IMGT Co., Ltd.
Genfleet Therapeutics (Shanghai) Inc.